Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data.
about
Zaleplon for insomniaZopiclone for insomniaZolpidem for insomniaInsomniaMagic bullets for insomnia? Patients' use and experiences of newer (Z drugs) versus older (benzodiazepine) hypnotics for sleep problems in primary careAbuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyondZopiclone: is it a pharmacologic agent for abuse?Neurophysiology of sleep and wakefulness: basic science and clinical implicationsEvaluation of the efficacy and safety of ramelteon in subjects with chronic insomniaSleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a comprehensive reviewPrescription Sedative Misuse and AbusePregabalin for the Treatment of Drug and Alcohol Withdrawal Symptoms: A Comprehensive ReviewLarval zebrafish model for FDA-approved drug repositioning for tobacco dependence treatmentThe effects of music relaxation and muscle relaxation techniques on sleep quality and emotional measures among individuals with posttraumatic stress disorder.Neural basis of benzodiazepine reward: requirement for α2 containing GABAA receptors in the nucleus accumbens.Raising awareness about sleep disorders.High-dose zolpidem dependence - Psychostimulant effects? A case report and literature reviewPharmacology of ramelteon, a selective MT1/MT2 receptor agonist: a novel therapeutic drug for sleep disordersTreatment options for sleep disturbances during alcohol recoveryMisuse of medicines in the European Union: a systematic review of the literature.BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP.The clinical and forensic toxicology of Z-drugs.Long-term misuse of zopiclone in an alcohol dependent woman with a history of anorexia nervosa: a case report.Adverse reactions to zolpidem: case reports and a review of the literature.Modest abuse-related subjective effects of zolpidem in drug-naive volunteers.Prior authorization of newer insomnia medications in managed care: is it cost saving?Clinical Practice Guideline for the Treatment of Intrinsic Circadian Rhythm Sleep-Wake Disorders: Advanced Sleep-Wake Phase Disorder (ASWPD), Delayed Sleep-Wake Phase Disorder (DSWPD), Non-24-Hour Sleep-Wake Rhythm Disorder (N24SWD), and Irregular SEfficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in adults with primary insomnia.Treatment of Insomnia, Insomnia Symptoms, and Obstructive Sleep Apnea During and After Menopause: Therapeutic ApproachesZolpidem Use Associated With Increased Risk of Pyogenic Liver Abscess: A Case-Control Study in TaiwanEszopiclone for the treatment of insomnia.Neurorobiology and evidence-based biological treatments for substance abuse disorders.Mechanisms of zolpidem-induced long QT syndrome: acute inhibition of recombinant hERG K(+) channels and action potential prolongation in human cardiomyocytes derived from induced pluripotent stem cellsPrevalence and Predictors of Prescription Sleep Aid Use among Individuals with DSM-5 Insomnia: The Role of Hyperarousal.Commentary on a critique for the Journal of Psychopharmacology: NICE--excellence or eccentricity? Reflections on the z-drugs as hypnotics review.Contribution of prolonged-release melatonin and anti-benzodiazepine campaigns to the reduction of benzodiazepine and Z-drugs consumption in nine European countriesCircadian dysregulation, zolpidem dependence, and withdrawal seizure in a resident physician performing shift work.A case of Zolpidem dependence successfully detoxified with gabapentin.Zolpidem dependence, abuse and withdrawal: A case report.Nonmedical Use of Antihistaminergic Anxiolytics and Other Prescription Drugs among Persons with Opioid Dependence.
P2860
Q24200706-33752AE7-77B7-4F15-B8B6-2044DBB29B8DQ24200717-BE199FD8-44C5-4548-BDBC-CC41F468B91EQ24200727-8C06DA33-1D5C-48C7-93E5-7D81322F4A49Q24632498-5448DF48-5017-44BA-A924-2E868B5B9A9BQ24642656-28E2925D-CD15-4140-ADA9-F3AD5FE2F2FCQ24644809-54DD691C-AD82-4236-84C8-0553D538AA39Q24653567-65C9E086-F9E2-49C9-BB55-D27AFA0FB9FAQ24658243-F466C53E-4E81-4F32-A613-D550F1ADE45DQ24683617-D64E1E3F-760B-418F-BCF2-04E26302BF88Q26749602-821854D2-2B91-4A12-ACE5-C17CCD50F3A9Q26785474-8C4DB71B-C3C6-4643-85B3-A48F946E668DQ28074617-24A5E977-C21D-497C-A09D-915322B98D8EQ28541293-89267370-7EBC-4326-84C8-58E4D491318DQ30369428-192E9433-67DF-464B-A2B3-BF47A49EA223Q30580823-21B8C601-DF38-49C7-A481-760EB22213D7Q33668591-E747AE46-7D1F-45DE-B37B-872511778924Q33820570-3937164D-5128-47CD-821F-E080C5FC77B0Q33854026-54E7B5BE-7A04-42C0-BC54-481EFF9870F4Q34115010-A0665DCE-174F-4D5F-8232-85017627BB7BQ34273774-5441021A-4050-4B55-A6DE-3F3B4944CAF7Q34277168-0BCE04A1-9C0F-484E-9060-2B01CAC78F66Q34327511-73468352-68E3-473F-8D47-EFF6D9F9EC81Q34461895-7839C106-1AC9-4303-90F5-BBAF314F1BCEQ34743052-FEA0E519-D685-456D-883E-755BB4D26CC7Q34802627-C1061352-0937-45B8-A8E7-985A32FA364AQ35995325-8476FA2E-9C45-4485-8479-C94C5AC82CC6Q36090692-FBFDC8EE-FFF9-4437-993B-F8830A195372Q36151458-746EC537-8F1E-4198-9191-83B14F2D5E85Q36165434-5FB92219-4F82-4760-A43E-3BB4B271E27AQ36195072-8D749E8A-1DD7-4AAA-A7C1-A79325BE4ED7Q36382595-2329EE06-5DD4-4898-99D6-FCF198F7BC3CQ36639800-045D9A9F-C962-42BF-9691-7885226483FAQ36675819-066B12FE-5CF5-4815-BBA5-170D8C0D7936Q36686496-FBA5A313-E046-4F5E-8CBF-C4A2ABFEA7FEQ36703422-6CE1C8E0-6081-4408-9379-0B895FAD6127Q36722184-F5AAD3AB-6882-4092-A2B6-1311E77E0FEAQ37097435-A82B7E67-1418-4762-B4B1-6714380406FFQ37183299-DD626F54-FAF6-44F2-9240-A89AFA2C518BQ37531875-9028AAD0-6D6A-4078-ABB7-2F1C2A89C278Q37549535-230640AE-D136-4C7E-830D-62B91B172D52
P2860
Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data.
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Abuse and dependence potential ...... orts and epidemiological data.
@ast
Abuse and dependence potential ...... orts and epidemiological data.
@en
type
label
Abuse and dependence potential ...... orts and epidemiological data.
@ast
Abuse and dependence potential ...... orts and epidemiological data.
@en
prefLabel
Abuse and dependence potential ...... orts and epidemiological data.
@ast
Abuse and dependence potential ...... orts and epidemiological data.
@en
P2093
P2860
P1433
P1476
Abuse and dependence potential ...... orts and epidemiological data.
@en
P2093
P2860
P304
P356
10.1046/J.1360-0443.2003.00491.X
P407
P577
2003-10-01T00:00:00Z